Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Medical Device Innovation Safety and Security Consortium (MDISS) is a non-profit public health organization dedicated to improving the cybersecurity and safety of connected medical devices. Founded in 2011, MDISS facilitates collaboration between healthcare providers, medical device manufacturers, and security researchers to develop best practices and technical standards. The organization is well-known for its work on the Manufacturer Disclosure Statement for Medical Device Security (MDS2) and the development of the World Health Information Security Testing Lab (WHISTL) network. By providing risk assessment tools and fostering information sharing, MDISS aims to protect patient safety from the evolving threats of cyberattacks on clinical infrastructure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medical Device Innovation Safety and Security Consortium.